参考文献

［1］ FU J, LEE K, CHUANG, P Y, et al. Glomerular endothelial cell injury and cross talk in diabetic kidney disease [J]. Am J Physiol Renal Physiol, 2015, 308 (4): F287-297.

［2］ FAN Y, LI X, XIAO W, et al. BAMBI elimination enhances alternative TGF-β signaling and glomerular dysfunction in diabetic mice [J]. Diabetes, 2015, 64 (6): 2220-2233.

［3］ BOELS M G, AVRAMUT M C, KOUDIJS A, et al. Atrasentan reduces albuminuria by restoring the glomerular endothelial glycocalyx barrier in diabetic nephropathy [J]. Diabetes, 2016, 65 (8): 2429-2439.

［4］ QI H, CASALENA G, SHI S, et al. Glomerular endothelial mitochondrial dysfunction is essential and characteristic of diabetic kidney disease susceptibility [J]. Diabetes, 2017, 66 (3): 763-778.

［5］ SANCHEZ M, ROUSSEL R, HADJADJ S, et al. Plasma concentrations of 8-hydroxy-2′-deoxyguanosine and risk of kidney disease and death in inpiduals with type 1 diabetes [J]. Diabetologia, 2018, 61 (4): 977-984.

［6］ MAESTRONI S, ZERBINI G. Glomerular endothelial cells versus podocytes as the cellular target in diabetic nephropathy [J]. Acta Diabetologica, 2018, 55 (16): 1-7.

［7］ LIZOTTE F, DENHEZ B, GUAY A, et al. Persistent Insulin Resistance in Podocytes caused by epigenetic changes of shp-1 in diabetes [J]. Diabetes, 2016, 65 (12): 3705-3717.

［8］ WANG X, YAO B, WANG Y, et al. Macrophage cyclooxygenase-2 protects against development of diabetic nephropathy [J]. Diabetes, 2017, 66 (2): 494-504.

［9］ PICHLER R, AFKARIAN M, DIETER B P, et al. Immunity and inflammation in diabetic kidney disease: translating mechanisms to biomarkers and treatment targets [J]. Am J Physiol Renal Physiol, 2017, 312 (4): F716-F731.

［10］ BETZ B B, JENKS S J, CRONSHAW A D, et al. Urinary peptidomics in a rodent model of diabetic nephropathy highlights epidermal growth factor as a biomarker for renal deterioration in patients with type 2 diabetes [J]. Kidney Int, 2016, 89 (5): 1125-1135.

［11］ ANDERBERG R J, MEEK R L, HUDKINS K L, et al. Serum amyloid A and inflammation in diabetic kidney disease and podocytes [J]. Lab Invest, 2015, 95 (3): 250-262.

［12］ MOHAMED R, JAYAKUMAR C, CHEN F, et al. Low-Dose IL-17 therapy prevents and reverses diabetic nephropathy, metabolic syndrome, and associated organ fibrosis [J]. J Am Soc Nephrol, 2016, 27 (3): 745-765.

［13］ GAGLIARDINI E, NOVELLI R, CORNA D, et al. B7-1 is not induced in podocytes of human and experimental diabetic nephropathy [J]. J Am Soc Nephrol, 2016, 27 (4): 999-1005.

［14］ HERRERA M, SÖDERBERG M, SABIRSH A, et al. Inhibition of T-cell activation by CTLA4-Fc is suff icient to ameliorate proteinuric kidney disease [J]. Am J Physiol Renal Physiol, 2017, 312 (4): F748-F759.

［15］ KRÖGER J, JACOBS S, JANSEN E H, et al. Erythrocyte membrane fatty acid fluidity and risk of type 2 diabetes in the EPIC-Potsdam study [J]. Diabetologia, 2015, 58 (2): 282-289.

［16］ HOGAN M F, HULL R L. The islet endothelial cell: a novel contributor to beta cell secretory dysfunction in diabetes [J]. Diabetologia, 2017, 60 (6): 952-959.

［17］ XING L, LIU Q, FU S, et al. PTEN Inhibits high glucose-induced phenotypic transition in podocytes [J]. J Cell Biochem, 2015, 116 (8): 1776-1784.

［18］ CHEN T, ZHENG LY, XIAO W, et al. Emodin ameliorates high glucose induced-podocyte epithelialmesenchymal transition in-vitro and in-vivo [J]. Cell Physiol Biochem, 2015, 35 (4): 1425-1436.

［19］ HUNTER C S, STEIN R W. Evidence for Loss in Identity, De-Differentiation, and Trans-Differentiation of Islet β-Cells in Type 2 Diabetes [J]. Front Genet, 2017, 8: 35.

［20］ MÜLLER S, DIAZ A. Metabolic stress and compromised identity of pancreatic beta cells [J]. Front Genet, 2017, 8: 73.

［21］ LIU W J, SHEN T T, CHEN R H, et al. Autophagy-lysosome pathway in renal tubular epithelial cells is disrupted by advanced glycation end products in diabetic nephropathy [J]. J Biol Chem, 2015, 290 (33): 20499-510.

［22］ XU L, FAN Q, WANG X, et al. Inhibition of autophagy increased AGE/ROS-mediated apoptosis in mesangial cells [J]. Cell Death Dis, 2016, 7 (11): e2445.

［23］ LENOIR O, JASIEK M, HÉNIQUE C, et al. Endothelial cell and podocyte autophagy synergistically protect from diabetes-induced glomerulosclerosis [J]. Autophagy, 2015, 11 (7): 1130-1145.